Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/25 12:50 | 4/2/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 16 | 0.5557 | 0 | 29 | 3 | 1,020 | D | |||||||||||||||
4/15/25 12:46 | 3/26/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 75 | 0.6041 | 0 | 123 | 14 | 992 | D | |||||||||||||||
4/15/25 12:40 | 3/18/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 31 | 0.6153 | 0 | 50 | 6 | 868 | D | |||||||||||||||
4/15/25 12:30 | 3/10/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 40 | 0.6156 | 0 | 64 | 9 | 818 | D | |||||||||||||||
4/15/25 12:22 | 2/25/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 30 | 0.6102 | 0 | 49 | 7 | 754 | D | |||||||||||||||
4/15/25 12:18 | 2/3/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 56 | 0.6572 | 0 | 84 | 14 | 705 | D | |||||||||||||||
4/15/25 12:11 | 1/27/25 | NBY | Health | Drug | Pharmaceutical Preparations | Poplar Point Capital Partners LP | CA | T | P.m | 68 | 0.6612 | 0 | 102 | 20 | 621 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |